Search research articles
Contact Us
Filters
Showing results (21-30 of 29) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 29 results.
International Journal of Biological Macromolecules
|
February 28, 2026
PANoptosis inhibition by Morchella sextelata polysaccharide mediates neuroprotection in Alzheimer's disease models
Chunyue Wang, Yue Guan, Jiaqi Chen, et al.
World Neurosurgery
|
November 17, 2019
Comparison of Subthalamic Nucleus and Globus Pallidus Internus Deep Brain Stimulation Surgery on Parkinson Disease-Related Pain
Shun Gong, Menting Xu, Yingqun Tao, et al.
Food Research International (Ottawa, Ont.)
|
May 22, 2026
Effects of partial KCl substitution for NaCl combined with LAB inoculation on the overall quality of Chouguiyu: A study based on safety, bacterial community structure, and flavor characteristics
Xiaohan Jia, Qixuan Pei, Bingrui Guo, et al.
CNS Neuroscience & Therapeutics
|
August 7, 2024
Safety and efficiency of deep brain stimulation in the elderly patients with Parkinson's disease
Weidong Wu, Shun Gong, Shimiao Wang, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 3, 2020
Discovery of nonpeptide 3,4-dihydroquinazoline-4-carboxamides as potent and selective sst2 agonists
Jian Zhao, Shimiao Wang, Sangdon Han, et al.
NPJ Parkinson'S Disease
|
October 21, 2020
A comparative study of asleep and awake deep brain stimulation robot-assisted surgery for Parkinson's disease
Hai Jin, Shun Gong, Yingqun Tao, et al.
ACS Medicinal Chemistry Letters
|
April 17, 2024
Discovery of CRN04894: A Novel Potent Selective MC2R Antagonist
Sun Hee Kim, Sangdon Han, Jian Zhao, et al.
ACS Medicinal Chemistry Letters
|
January 19, 2023
Discovery of Paltusotine (CRN00808), a Potent, Selective, and Orally Bioavailable Non-peptide SST2 Agonist
Jian Zhao, Shimiao Wang, Stacy Markison, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 23, 2022
Discovery of 4-(3-aminopyrrolidinyl)-3-aryl-5-(benzimidazol-2-yl)-pyridines as potent and selective SST5 agonists for the treatment of congenital hyperinsulinism
Jian Zhao, Shimiao Wang, Sun Hee Kim, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 29) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 29 results.
International Journal of Biological Macromolecules
|
February 28, 2026
PANoptosis inhibition by Morchella sextelata polysaccharide mediates neuroprotection in Alzheimer's disease models
Chunyue Wang, Yue Guan, Jiaqi Chen, et al.
World Neurosurgery
|
November 17, 2019
Comparison of Subthalamic Nucleus and Globus Pallidus Internus Deep Brain Stimulation Surgery on Parkinson Disease-Related Pain
Shun Gong, Menting Xu, Yingqun Tao, et al.
Food Research International (Ottawa, Ont.)
|
May 22, 2026
Effects of partial KCl substitution for NaCl combined with LAB inoculation on the overall quality of Chouguiyu: A study based on safety, bacterial community structure, and flavor characteristics
Xiaohan Jia, Qixuan Pei, Bingrui Guo, et al.
CNS Neuroscience & Therapeutics
|
August 7, 2024
Safety and efficiency of deep brain stimulation in the elderly patients with Parkinson's disease
Weidong Wu, Shun Gong, Shimiao Wang, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 3, 2020
Discovery of nonpeptide 3,4-dihydroquinazoline-4-carboxamides as potent and selective sst2 agonists
Jian Zhao, Shimiao Wang, Sangdon Han, et al.
NPJ Parkinson'S Disease
|
October 21, 2020
A comparative study of asleep and awake deep brain stimulation robot-assisted surgery for Parkinson's disease
Hai Jin, Shun Gong, Yingqun Tao, et al.
ACS Medicinal Chemistry Letters
|
April 17, 2024
Discovery of CRN04894: A Novel Potent Selective MC2R Antagonist
Sun Hee Kim, Sangdon Han, Jian Zhao, et al.
ACS Medicinal Chemistry Letters
|
January 19, 2023
Discovery of Paltusotine (CRN00808), a Potent, Selective, and Orally Bioavailable Non-peptide SST2 Agonist
Jian Zhao, Shimiao Wang, Stacy Markison, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 23, 2022
Discovery of 4-(3-aminopyrrolidinyl)-3-aryl-5-(benzimidazol-2-yl)-pyridines as potent and selective SST5 agonists for the treatment of congenital hyperinsulinism
Jian Zhao, Shimiao Wang, Sun Hee Kim, et al.
Page
of 3